Ionica Sciences, Inc

Medtech · Private

A multiplexed biomarker detection platform using DNA aptamers and Surface Enhanced Raman Scattering (SERS) to rapidly detect tau protein (TBI) and procalcitonin (sepsis) in blood samples

Grants
$555K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$100K
1 award · Defense
#526 of 4531 in medtech
Patents
5
1 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · Igf::ct::igf Darpa SBIR Phase I Entitled "surface Enhanced Raman Scattering-based Oxytocin Quantitation"$99,618
Federal grantDepartment of Defense · Phase I · Real time detection of stress- and fatigue-related biomarkers using vibrational spectroscopy$149,990
Federal grantDepartment of Defense · Phase I · Rapid SERS-based Detection of Sepsis and TBI Biomarkers$149,999
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Rapid Antigen-based SERS assay for COVID-19 Detection (COVID-19)$255,468
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
523ROCHAL INDUSTRIES, LLP$100K—
524PROFUSA, INC.$100K$59M
525Surfplasma, Inc.$100K—
526Ionica Sciences, Inc$100K—
527QUANTIPORT, INC.$98K—
528CenTrak, Inc.$98K$832K
529HIGHLAND INSTRUMENTS INC$98K$750K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 5
  • Reagents And Methods For Detecting Infectious Diseasesapplication
  • Reagents And Methods For Detecting Infectious Diseasesgranted
  • Reagents And Methods For Detecting Infectious Diseasesapplication
  • Reagents and Methods for Detecting Lyme Diseaseapplication
  • Reagents and Methods for Detecting Infectious Diseasesapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.